Median LCS (internal name) / eyonis LCS (trade name) (1.0)

by Median Technologies  · Based in United States → — Pioneering innovative software as a medical device and imaging services, Median Technologies harnesses cutting-edge AI to enhance the accuracy of early cancer diagnoses and treatments.
Oncology Pulmonology Radiology

Regulatory Status Disclosed

Overview

Median Technologies’ eyonis LCS (Lung Cancer Screening) is an AI/ML-powered Software as a Medical Device (SaMD) designed to aid in the detection and diagnosis of lung cancer in screening programs. It helps clinicians detect lung parenchymal nodules on low-dose CT (LDCT) scans and characterize them as probably benign, suspicious, or very suspicious, supporting early cancer diagnosis, patient risk stratification, and improved clinical management. The tool aims to address the challenges of false positives and false negatives that can hamper existing lung cancer screening programs. eyonis LCS is the first AI-based tool to combine computer-aided detection and diagnosis directly within the diagnostic care pathway of LDCT lung cancer screening. It provides both nodule detection capabilities and a nodule-specific malignancy score to support clinical decision-making.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI/ML-powered computer-aided detection (CADe) and diagnosis (CADx) for lung cancer screening
  • Detects and characterizes lung parenchymal nodules on LDCT scans
  • Provides nodule-specific malignancy score and Likelihood of Malignancy (LOM%) from 1% to 93%
  • Reduces false positives by 68% and false negatives by 66% compared to unaided radiologists
  • Achieves 93.3% sensitivity and 92.4% specificity
  • Offers 99.9% Negative Predictive Value (NPV)
  • Generates DICOM file result reports, compatible with PACS
  • Flexible deployment: cloud-based or institution local hosting
  • Integrates with existing workflows and PACS
  • Supports patient risk stratification and improved clinical management

Use Cases

  • Early detection and diagnosis of lung cancer in screening programs
  • Reducing unnecessary follow-up procedures and patient anxiety
  • Improving diagnostic confidence and screening efficiency for radiologists
  • Supporting clinical decision-making from nodule identification through patient management
  • Scaling lung cancer screening programs with enhanced accuracy and efficiency
  • Addressing radiology capacity constraints and workforce shortages

Details

Category Clinical Decision Support & Reference, Oncology AI, Radiology & Imaging AI
Pricing Unknown
DeploymentCloud-based or institution local hosting.
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Oncology, Pulmonology, Radiology

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2026-02-06K251474 510(k)Median LCS (internal name) / eyonis LCS (trade name) (1.0)

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Median LCS (internal name) / eyonis LCS (trade name) (1.0)

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Median LCS (internal name) / eyonis LCS (trade name) (1.0).

Loading videos...

View all on YouTube

No FAQs available yet for this tool.

Related Tools

Stanford University
Stanford University
Clinical Decision Support & Reference
Stanford Online's "AI in Healthcare" program provides a comprehensive overview of artificial intelligence's applications and implications within the medical field.
RADIN Health
RADIN Health
Clinical Decision Support & Reference
RADINA is an AI-powered platform by RADIN Health designed to optimize radiology workflows, enhance diagnostic accuracy, and streamline reporting.
Med-PaLM 2
Google
Clinical Decision Support & Reference
Med-PaLM 2 is a large language model from Google, fine-tuned for healthcare to provide high-quality answers to medical questions and support clinical decision-making.
Pacmed Critical Discharge
Pacmed
Clinical Decision Support & Reference
Pacmed Critical Discharge is an AI tool that predicts the probability of death or readmission within seven days of ICU discharge, providing explainable insights for physicians.
AiZtech Labs
AiZtech Labs
Clinical Decision Support & Reference
AiZtech Labs provides enterprise-grade AI solutions for healthcare, focusing on operational efficiency, diagnostic accuracy, and patient care workflows for providers and health systems.
Stethophone Pro
Sparrow Acoustics
Cardiology AI
Stethophone Pro transforms smartphones into advanced cardiac screening tools, enabling clinicians to capture, interpret, and visualize heart sounds for early detection of cardiovascular diseases.

See all Clinical Decision Support & Reference tools →

More from Median Technologies

eyonis® LCS
Median Technologies
Oncology AI

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-19 | First Added: 2026-11-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.